Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Nalbuphine vs Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries
NCT05041270Completed
- Sponsor
- Zagazig University
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of nalbuphine and dexmedetomidine in postoperative pain (3 arms), sponsored by Zagazig University. Primary endpoints: Duration of epidural analgesia and Maximum level of sensory blockade at 30 minutes. Started Oct 2021; status: completed.
02
Drugs
nalbuphinedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05041270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05041270.